Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease

Gut Microbes

Volumn 4, Issue 2, 2013, Pages 101-117

  Bridge, Dacie R ^a   Scott Merrell, D ^a  

^a Uniformed Services University of the Health Sciences   (United States)

Author keywords

CagA; Helicobacter pylori; VacA

Indexed keywords

CAGA PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 8; PROTEIN TYROSINE PHOSPHATASE SHP 2; RHO KINASE; TRANSFORMING GROWTH FACTOR BETA; VACUOLATING TOXIN;

ALLERGY; AMINO ACID SEQUENCE; ARTICLE; ASTHMA; CLASSIFICATION; ESOPHAGUS CANCER; GASTRITIS; HEALTH; HELICOBACTER INFECTION; HUMAN; MICROBIOME; NONHUMAN; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN POLYMORPHISM;

CAGA; HELICOBACTER PYLORI; VACA;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; GENETIC VARIATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; VIRULENCE FACTORS;

EID: 84874750849     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.23797     Document Type: Article

References (208)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulcer-ation. Lancet 1984; 1:1311-1315; PMID:6145023; http://dx.doi.org/10.1016/S0140-6736(84)91816-6.
2. Parsonnet J, Friedman GD, Vandersteen D P, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-1131; PMID:1891020; http://dx.doi.org/10.1056/NEJM199110173251603.
3. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330:1267-1271; PMID:8145781; http://dx.doi.org/10.1056/NEJM199405053301803.
4. Pritchard DM, Crabtree JE. Helicobacter pylori and gastric cancer. Curr Opin Gastroenterol 2006; 22:620-625; PMID:17053439; http://dx.doi.org/10.1097/01.mog.0000245539.50765.f6.
5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-789; PMID:11556297; http://dx.doi.org/10.1056/NEJMoa001999.
6. Infection with. Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization. International Agency for Research on Cancer 1994; 61:177-240.
7. Perez-Perez GI, Salomaa A, Kosunen TU, Daverman B, Rautelin H, Aromaa A, et al. Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut 2002; 50:295-298; PMID:11839704; http://dx.doi.org/10.1136/gut.50.3.295.
8. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999; 284:1328-1333; PMID:10334982; http://dx.doi.org/10.1126/sci-ence.284.5418.1328.
9. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007; 445:915-918; PMID:17287725; http://dx.doi.org/10.1038/nature05562.
10. Kersulyte D, Kalia A, Gilman RH, Mendez M, Herrera P, Cabrera L, et al. Helicobacter pylori from Peruvian amerindians: traces of human migrations in strains from remote Amazon, and genome sequence of an Amerind strain. PLoS One 2010; 5:e15076; PMID:21124785; http://dx.doi.org/10.1371/journal.pone.0015076.
11. Wirth T, Wang X, Linz B, Novick R P, Lum JK, Blaser M, et al. Distinguishing human ethnic groups by means of sequences from Helicobacter pylori: lessons from Ladakh. Proc Natl Acad Sci U S A 2004; 101:4746-4751; PMID:15051885; http://dx.doi.org/10.1073/pnas.0306629101.
12. Moodley Y, Linz B. Helicobacter pylori Sequences Reflect Past Human Migrations. Genome Dyn 2009; 6:62-74; PMID:19696494; http://dx.doi.org/10.1159/000235763.
13. Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, Kidd M, et al. Traces of human migrations in Helicobacter pylori populations. Science 2003; 299:1582-1585; PMID:12624269; http://dx.doi.org/10.1126/science.1080857.
14. Moodley Y, Linz B, Yamaoka Y, Windsor HM, Breurec S, Wu JY, et al. The peopling of the Pacific from a bacterial perspective. Science 2009; 323:527-530; PMID:19164753; http://dx.doi.org/10.1126/science.1166083.
15. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, et al. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 1996; 93:14648-14653; PMID:8962108; http://dx.doi.org/10.1073/pnas.93.25.14648.
16. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci U S A 1999; 96:14559-14564; PMID:10588744; http://dx.doi.org/10.1073/pnas.96.25.14559.
17. Xiang Z, Censini S, Bayeli P F, Telford JL, Figura N, Rappuoli R, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63:94-98; PMID:7806390.
18. Yamaoka Y, Osato MS, Sepulveda AR, Gutierrez O, Figura N, Kim JG, et al. Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect 2000; 124:91-96; PMID:10722135; http://dx.doi.org/10.1017/S0950268899003209.
19. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric patho-gen Helicobacter pylori. Nature 1999; 397:176-180; PMID:9923682; http://dx.doi.org/10.1038/16495.
20. Kersulyte D, Mukhopadhyay AK, Velapatiño B, Su W, Pan Z, Garcia C, et al. Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol 2000; 182:3210-3218; PMID:10809702; http://dx.doi.org/10.1128/JB.182.11.3210-3218.2000.
21. Yamazaki S, Yamakawa A, Okuda T, Ohtani M, Suto H, Ito Y, et al. Distinct diversity of vacA, cagA, and cagE genes of Helicobacter pylori associated with peptic ulcer in Japan. J Clin Microbiol 2005; 43:3906-3916; PMID:16081930; http://dx.doi.org/10.1128/JCM.43.8.3906-3916.2005.
22. Truong BX, Mai VT, Tanaka H, Ly T, Thong TM, Hai HH, et al. Diverse characteristics of the CagA gene of Helicobacter pylori strains collected from patients from southern vietnam with gastric cancer and peptic ulcer. J Clin Microbiol 2009; 47:4021-4028; PMID:19846630; http://dx.doi.org/10.1128/JCM.00504-09.
23. Duncan SS, Valk PL, Shaffer CL, Bordenstein SR, Cover TL. J-Western forms of Helicobacter pylori cagA constitute a distinct phylogenetic group with a widespread geographic distribution. J Bacteriol 2012; 194:1593-1604; PMID:22247512; http://dx.doi.org/10.1128/JB.06340-11.
24. Mane S P, Dominguez-Bello MG, Blaser MJ, Sobral BW, Hontecillas R, Skoneczka J, et al. Host-interactive genes in Amerindian Helicobacter pylori diverge from their Old World homologs and mediate inflam-matory responses. J Bacteriol 2010; 192:3078-3092; PMID:20400544; http://dx.doi.org/10.1128/JB.00063-10.
25. Suzuki M, Kiga K, Kersulyte D, Cok J, Hooper CC, Mimuro H, et al. Attenuated CagA oncop-rotein in Helicobacter pylori from Amerindians in Peruvian Amazon. J Biol Chem 2011; 286:29964-29972; PMID:21757722; http://dx.doi.org/10.1074/jbc.M111.263715.
26. Correa P, Piazuelo MB. Evolutionary History of the Helicobacter pylori Genome: Implications for Gastric Carcinogenesis. Gut Liver 2012; 6:21-28; PMID:22375167; http://dx.doi.org/10.5009/gnl.2012.6.1.21.
27. Devi SM, Ahmed I, Francalacci P, Hussain MA, Akhter Y, Alvi A, et al. Ancestral European roots of Helicobacter pylori in India. BMC Genomics 2007; 8:184; PMID:17584914; http://dx.doi.org/10.1186/1471-2164-8-184.
28. Tay CY, Mitchell H, Dong Q, Goh KL, Dawes IW, Lan R. Population structure of Helicobacter pylori among ethnic groups in Malaysia: recent acquisition of the bacterium by the Malay population. BMC Microbiol 2009; 9:126; PMID:19538757; http://dx.doi.org/10.1186/1471-2180-9-126.
29. Zevit N, Balicer RD, Cohen HA, Karsh D, Niv Y, Shamir R. Inverse association between Helicobacter pylori and pediatric asthma in a high-prevalence popu-lation. Helicobacter 2012; 17:30-35; PMID:22221613; http://dx.doi.org/10.1111/j.1523-5378.2011.00895.x.
30. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008; 198:553-560; PMID:18598192; http://dx.doi.org/10.1086/590158.
31. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 2007; 167:821-827; PMID:17452546; http://dx.doi.org/10.1001/archinte.167.8.821.
32. Reibman J, Marmor M, Filner J, Fernandez-Beros ME, Rogers L, Perez-Perez GI, et al. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One 2008; 3:e4060; PMID:19112508; http://dx.doi.org/10.1371/journal. pone.0004060.
33. Strachan D P. Hay fever, hygiene, and household size. BMJ 1989; 299:1259-1260; PMID:2513902; http://dx.doi.org/10.1136/bmj.299.6710.1259.
34. Perry S, de Jong BC, Solnick JV, de la Luz Sanchez M, Yang S, Lin PL, et al. Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One 2010; 5:e8804; PMID:20098711; http://dx.doi.org/10.1371/journal.pone.0008804.
35. Perry S, Chang AH, Sanchez L, Yang S, Haggerty TD, Parsonnet J. The immune response to tuber-culosis infection in the setting of Helicobacter pylori and helminth infections. Epidemiol Infect 2012; In press; PMID:22954328; http://dx.doi.org/10.1017/S0950268812001823.
36. Francois F, Roper J, Joseph N, Pei Z, Chhada A, Shak JR, et al. The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin. BMC Gastroenterol 2011; 11:37; PMID:21489301; http://dx.doi.org/10.1186/1471-230X-11-37.
37. Malfertheiner P, Selgrad M. Helicobacter pylori infection and current clinical areas of contention. Curr Opin Gastroenterol 2010; 26:618-623; PMID:20827182; http://dx.doi.org/10.1097/MOG.0b013e32833efede.
38. Chen Y, Blaser MJ. Association between gastric Helicobacter pylori colonization and glycated hemo-globin levels. J Infect Dis 2012; 205:1195-1202; PMID:22427676; http://dx.doi.org/10.1093/infdis/jis106.
39. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylo-ri infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 2007; 5:1413-1417, 1417, e1-e2; PMID:17997357; http://dx.doi.org/10.1016/j.cgh.2007.08.010.
40. de Martel C, Llosa AE, Farr SM, Friedman GD, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of development of esopha-geal adenocarcinoma. J Infect Dis 2005; 191:761-767; PMID:15688293; http://dx.doi.org/10.1086/427659.
41. Vaezi MF, Falk GW, Peek RM, Vicari JJ, Goldblum JR, Perez-Perez GI, et al. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol 2000; 95:2206-2211; PMID:11007219; http://dx.doi.org/10.1111/j.1572-0241.2000.02305.x.
42. Miernyk K, Morris J, Bruden D, McMahon B, Hurlburt D, Sacco F, et al. Characterization of Helicobacter pylori cagA and vacA genotypes among Alaskans and their correlation with clinical disease. J Clin Microbiol 2011; 49:3114-3121; PMID:21752979; http://dx.doi.org/10.1128/JCM.00469-11.
43. Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, et al. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut 2008; 57:727-733; PMID:17895354; http://dx.doi.org/10.1136/gut.2007.132068.
44. Corley DA, Kubo A, Levin TR, Block G, Habel L, Rumore G, et al. Helicobacter pylori and gastroesopha-geal reflux disease: a case-control study. Helicobacter 2008; 13:352-360; PMID:19250510; http://dx.doi.org/10.1111/j.1523-5378.2008.00624.x.
45. Fischbach LA, Nordenstedt H, Kramer JR, Gandhi S, Dick-Onuoha S, Lewis A, et al. The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter 2012; 17:163-175; PMID:22515353; http://dx.doi.org/10.1111/j.1523-5378.2011.00931.x.
46. Merrell DS, Falkow S. Frontal and stealth attack strate-gies in microbial pathogenesis. Nature 2004; 430:250-256; PMID:15241423; http://dx.doi.org/10.1038/nature02760.
47. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology 2009; 136:1863-1873; PMID:19457415; http://dx.doi.org/10.1053/j.gas-tro.2009.01.073.
48. Dorer MS, Talarico S, Salama NR. Helicobacter pylori' s unconventional role in health and disease. PLoS Pathog 2009; 5:e1000544; PMID:19855816; http://dx.doi.org/10.1371/journal.ppat.1000544.
49. Robinson K, Argent RH, Atherton JC. The inflamma-tory and immune response to Helicobacter pylori infec-tion. Best Pract Res Clin Gastroenterol 2007; 21:237-259; PMID:17382275; http://dx.doi.org/10.1016/j.bpg.2007.01.001.
50. Arnold IC, Hitzler I, Müller A. The Immunomodulatory Properties of Helicobacter pylori Confer Protection Against Allergic and Chronic Inflammatory Disorders. Front Cell Infect Microbiol 2012; 2:10; PMID:22919602; http://dx.doi.org/10.3389/fcimb.2012.00010.
51. Kabir S. The role of interleukin-17 in the Helicobacter pylori induced infection and immunity. Helicobacter 2011; 16:1-8; PMID:21241406; http://dx.doi.org/10.1111/j.1523-5378.2010.00812.x.
52. Eaton KA, Ringler SR, Danon SJ. Murine splenocytes induce severe gastritis and delayed-type hypersensitivity and suppress bacterial colonization in Helicobacter pylo-ri-infected SCID mice. Infect Immun 1999; 67:4594-4602; PMID:10456905.
53. Robinson K, Kenefeck R, Pidgeon EL, Shakib S, Patel S, Polson RJ, et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 2008; 57:1375-1385; PMID:18467372; http://dx.doi.org/10.1136/gut.2007.137539.
54. Arnold IC, Lee JY, Amieva MR, Roers A, Flavell RA, Sparwasser T, et al. Tolerance rather than immu-nity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology 2011; 140:199-209; PMID:20600031; http://dx.doi.org/10.1053/j.gas-tro.2010.06.047.
55. Harris PR, Wright SW, Serrano C, Riera F, Duarte I, Torres J, et al. Helicobacter pylori gastritis in chil-dren is associated with a regulatory T-cell response. Gastroenterology 2008; 134:491-499; PMID:18242215; http://dx.doi.org/10.1053/j.gastro.2007.11.006.
56. Sharma SA, Tummuru MK, Blaser MJ, Kerr LD. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol 1998; 160:2401-2407; PMID:9498783.
57. Crabtree JE, Xiang Z, Lindley IJ, Tompkins DS, Rappuoli R, Covacci A. Induction of interleukin-8 secretion from gastric epithelial cells by a cagA nega-tive isogenic mutant of Helicobacter pylori. J Clin Pathol 1995; 48:967-969; PMID:8537502; http://dx.doi.org/10.1136/jcp.48.10.967.
58. Hitzler I, Kohler E, Engler DB, Yazgan AS, Müller A. The role of Th cell subsets in the control of Helicobacter infections and in T cell-driven gastric immunopathol-ogy. Front Immunol 2012; 3:142; PMID:22675328; http://dx.doi.org/10.3389/fimmu.2012.00142.
59. Horvath DJ Jr., Washington MK, Cope VA, Algood HM. IL-23 Contributes to Control of Chronic Helicobacter Pylori Infection and the Development of T Helper Responses in a Mouse Model. Front Immunol 2012; 3:56; PMID:22566937; http://dx.doi.org/10.3389/fimmu.2012.00056.
60. Serelli-Lee V, Ling KL, Ho C, Yeong LH, Lim GK, Ho B, et al. Persistent Helicobacter pylori specific Th17 responses in patients with past H. pylori infection are associated with elevated gastric mucosal IL-1β. PLoS One 2012; 7:e39199; PMID:22761739; http://dx.doi.org/10.1371/journal.pone.0039199.
61. López-Carrillo L, Camargo MC, Schneider BG, Sicinschi LA, Hernández-Ramírez RU, Correa P, et al. Capsaicin consumption, Helicobacter pylori CagA status and IL1B-31C>T genotypes: a host and environ-ment interaction in gastric cancer. Food Chem Toxicol 2012; 50:2118-2122; PMID:22414649; http://dx.doi.org/10.1016/j.fct.2012.02.043.
62. López-Carrillo L, López-Cervantes M, Robles-Díaz G, Ramírez-Espitia A, Mohar-Betancourt A, Meneses-García A, et al. Capsaicin consumption, Helicobacter pylori positivity and gastric cancer in Mexico. Int J Cancer 2003; 106:277-282; PMID:12800206; http://dx.doi.org/10.1002/ijc.11195.
63. Liu H, Merrell DS, Semino-Mora C, Goldman M, Rahman A, Mog S, et al. Diet synergistically affects helicobacter pylori-induced gastric carcinogen-esis in nonhuman primates. Gastroenterology 2009; 137:1367-1379, e1-6; PMID:19622359; http://dx.doi.org/10.1053/j.gastro.2009.07.041.
64. González CA, López-Carrillo L. Helicobacter pylo-ri, nutrition and smoking interactions: their impact in gastric carcinogenesis. Scand J Gastroenterol 2010; 45:6-14; PMID:20030576; http://dx.doi.org/10.3109/00365520903401959.
65. Odenbreit S, Püls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287:1497-1500; PMID:10688800; http://dx.doi.org/10.1126/science.287.5457.1497.
66. Stein M, Rappuoli R, Covacci A. Tyrosine phosphory-lation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A 2000; 97:1263-1268; PMID:10655519; http://dx.doi.org/10.1073/pnas.97.3.1263.
67. Tan S, Tompkins LS, Amieva MR. Helicobacter pylori usurps cell polarity to turn the cell surface into a replicative niche. PLoS Pathog 2009; 5:e1000407; PMID:19412339; http://dx.doi.org/10.1371/journal.ppat.1000407.
68. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003; 300:1430-1434; PMID:12775840; http://dx.doi.org/10.1126/science.1081919.
69. Tanaka H, Yoshida M, Nishiumi S, Ohnishi N, Kobayashi K, Yamamoto K, et al. The CagA protein of Helicobacter pylori suppresses the functions of dendritic cell in mice. Arch Biochem Biophys 2010; 498:35-42; PMID:20363211; http://dx.doi.org/10.1016/j.abb.2010.03.021.
70. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A 1993; 90:5791-5795; PMID:8516329; http://dx.doi.org/10.1073/pnas.90.12.5791.
71. Murata-Kamiya N, Kikuchi K, Hayashi T, Higashi H, Hatakeyama M. Helicobacter pylori exploits host mem-brane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe 2010; 7:399-411; PMID:20478541; http://dx.doi.org/10.1016/j.chom.2010.04.005.
72. Selbach M, Moese S, Hauck CR, Meyer T F, Backert S. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 2002; 277:6775-6778; PMID:11788577; http://dx.doi.org/10.1074/jbc.C100754200.
73. Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, Covacci A. C-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol Microbiol 2002; 43:971-980; PMID:11929545; http://dx.doi.org/10.1046/j.1365-2958.2002.02781.x.
74. Poppe M, Feller SM, Römer G, Wessler S. Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene 2007; 26:3462-3472; PMID:17160020; http://dx.doi.org/10.1038/sj.onc.1210139.
75. Tammer I, Brandt S, Hartig R, König W, Backert S. Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterology 2007; 132:1309-1319; PMID:17408661; http://dx.doi.org/10.1053/j.gas-tro.2007.01.050.
76. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori Cag. Protein Sci 2002; 295:683-686.
77. Backert S, Tegtmeyer N, Selbach M. The versatility of Helicobacter pylori CagA effector protein functions: The master key hypothesis. Helicobacter 2010; 15:163-176; PMID:20557357; http://dx.doi.org/10.1111/j.1523-5378.2010.00759.x.
78. Jones KR, Whitmire JM, Merrell DS. A Tale of Two Toxins: Helicobacter Pylori CagA and VacA Modulate Host Pathways that Impact Disease. Front Microbiol 2010; 1:115; PMID:21687723; http://dx.doi.org/10.3389/fmicb.2010.00115.
79. Hatakeyama M. Helicobacter pylori and gastric car-cinogenesis. J Gastroenterol 2009; 44:239-248; PMID:19271114; http://dx.doi.org/10.1007/s00535-009-0014-1.
80. Higashi H, Nakaya A, Tsutsumi R, Yokoyama K, Fujii Y, Ishikawa S, et al. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 2004; 279:17205-17216; PMID:14963045; http://dx.doi.org/10.1074/jbc.M309964200.
81. Kikuchi K, Murata-Kamiya N, Kondo S, Hatakeyama M. Helicobacter pylori stimulates epithelial cell migra-tion via CagA-mediated perturbation of host cell signaling. Microbes Infect 2012; 14:470-476; PMID:22202178; http://dx.doi.org/10.1016/j.micinf.2011.12.003.
82. Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007; 447:330-333; PMID:17507984; http://dx.doi.org/10.1038/nature05765.
83. Ishikawa S, Ohta T, Hatakeyama M. Stability of Helicobacter pylori CagA oncoprotein in human gas-tric epithelial cells. FEBS Lett 2009; 583:2414-2418; PMID:19560464; http://dx.doi.org/10.1016/j.febs-let.2009.06.043.
84. Suzuki M, Mimuro H, Kiga K, Fukumatsu M, Ishijima N, Morikawa H, et al. Helicobacter pylo-ri CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 2009; 5:23-34; PMID:19154985; http://dx.doi.org/10.1016/j.chom.2008.11.010.
85. Sohn SH, Lee YC. The genome-wide expression profile of gastric epithelial cells infected by naturally occurring cagA isogenic strains of Helicobacter pylori. Environ Toxicol Pharmacol 2011; 32:382-389; PMID:22004957; http://dx.doi.org/10.1016/j.etap.2011.08.006.
86. Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci U S A 2005; 102:16339-16344; PMID:16258069; http://dx.doi.org/10.1073/pnas.0502598102.
87. Higashi H, Yokoyama K, Fujii Y, Ren S, Yuasa H, Saadat I, et al. EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J Biol Chem 2005; 280:23130-23137; PMID:15831497; http://dx.doi.org/10.1074/jbc.M503583200.
88. Pelz C, Steininger S, Weiss C, Coscia F, Vogelmann R. A novel inhibitory domain of Helicobacter pylori protein CagA reduces CagA effects on host cell biology. J Biol Chem 2011; 286:8999-9008; PMID:21212271; http://dx.doi.org/10.1074/jbc.M110.166504.
89. Steininger S, Pelz C, Vogelmann R. Purpose of recent-ly detected inhibitory domain of the Helicobacter pylori protein CagA. Gut Microbes 2011; 2:167-172; PMID:21637033; http://dx.doi.org/10.4161/gmic.2.3.15872.
90. Hayashi T, Senda M, Morohashi H, Higashi H, Horio M, Kashiba Y, et al. Tertiary structure-function analysis reveals the pathogenic signaling potentiation mecha-nism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe 2012; 12:20-33; PMID:22817985; http://dx.doi.org/10.1016/j.chom.2012.05.010.
91. Nesic D, Miller MC, Quinkert Z T, Stein M, Chait B T, Stebbins CE. Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates. Nat Struct Mol Biol 2010; 17:130-132; PMID:19966800; http://dx.doi.org/10.1038/nsmb.1705.
92. Backert S, Tegtmeyer N. Helicobacter pylori CagA tertiary structure reveals functional insights. Cell Host Microbe 2012; 12:3-5; PMID:22817982; http://dx.doi.org/10.1016/j.chom.2012.07.001.
93. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A 2002; 99:14428-14433; PMID:12391297; http://dx.doi.org/10.1073/pnas.222375399.
94. Ren S, Higashi H, Lu H, Azuma T, Hatakeyama M. Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J Biol Chem 2006; 281:32344-32352; PMID:16954210; http://dx.doi.org/10.1074/jbc.M606172200.
95. van der Wouden JM, Maier O, van Ijzendoorn SC, Hoekstra D. Membrane dynamics and the regulation of epithelial cell polarity. Int Rev Cytol 2003; 226:127-164; PMID:12921237; http://dx.doi.org/10.1016/S0074-7696(03)01003-9.
96. Wang Q, Margolis B. Apical junctional complex-es and cell polarity. Kidney Int 2007; 72:1448-1458; PMID:17914350; http://dx.doi.org/10.1038/sj.ki.5002579.
97. van Staveren WC, Solís DY, Hébrant A, Detours V, Dumont JE, Maenhaut C. Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells? Biochim Biophys Acta 2009; 1795:92-103; PMID:19167460.
98. Argent RH, Hale JL, El-Omar EM, Atherton JC. Differences in Helicobacter pylori CagA tyrosine phos-phorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. J Med Microbiol 2008; 57:1062-1067; PMID:18719174; http://dx.doi.org/10.1099/jmm.0.2008/001818-0.
99. Camorlinga-Ponce M, Perez-Perez G, Gonzalez-Valencia G, Mendoza I, Peñaloza-Espinosa R, Ramos I, et al. Helicobacter pylori genotyping from American indigenous groups shows novel Amerindian vacA and cagA alleles and Asian, African and European admix-ture. PLoS One 2011; 6:e27212; PMID:22073291; http://dx.doi.org/10.1371/journal.pone.0027212.
100. Shiota S, Matsunari O, Yamaoka Y. Relationship between J-Western CagA subtype and the vacA m2 region of Helicobacter pylori. J Clin Microbiol 2010; 48:3033-3034; PMID:20519467; http://dx.doi.org/10.1128/JCM.00983-10.
101. Furuta Y, Yahara K, Hatakeyama M, Kobayashi I. Evolution of cagA oncogene of Helicobacter pylori through recombination. PLoS One 2011; 6:e23499; PMID:21853141; http://dx.doi.org/10.1371/journal.pone.0023499.
102. Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, et al. C-Src and c-Abl kinas-es control hierarchic phosphorylation and func-tion of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest 2012; 122:1553-1566; PMID:22378042; http://dx.doi.org/10.1172/JCI61143.
103. Hatakeyama M, Higashi H. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci 2005; 96:835-843; PMID:16367902; http://dx.doi.org/10.1111/j.1349-7006.2005.00130.x.
104. Azuma T, Yamazaki S, Yamakawa A, Ohtani M, Muramatsu A, Suto H, et al. Association between diversity in the Src homology 2 domain--containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis 2004; 189:820-827; PMID:14976598; http://dx.doi.org/10.1086/381782.
105. Naito M, Yamazaki T, Tsutsumi R, Higashi H, Onoe K, Yamazaki S, et al. Influence of EPIYA-repeat polymor-phism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 2006; 130:1181-1190; PMID:16618412; http://dx.doi.org/10.1053/j.gastro.2005.12.038.
106. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004; 4:688-694; PMID:15343275; http://dx.doi.org/10.1038/nrc1433.
107. Nagase L, Murata-Kamiya N, Hatakeyama M. Potentiation of Helicobacter pylori CagA protein virulence through homodimerization. J Biol Chem 2011; 286:33622-33631; PMID:21813645; http://dx.doi.org/10.1074/jbc.M111.258673.
108. Tsutsumi R, Higashi H, Higuchi M, Okada M, Hatakeyama M. Attenuation of Helicobacter pylo-ri CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J Biol Chem 2003; 278:3664-3670; PMID:12446738; http://dx.doi.org/10.1074/jbc.M208155200.
109. Yamaoka Y, El-Zimaity HM, Gutierrez O, Figura N, Kim JG, Kodama T, et al. Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric his-tology, and susceptibility to low pH. Gastroenterology 1999; 117:342-349; PMID:10419915; http://dx.doi.org/10.1053/gast.1999.0029900342.
110. Basso D, Zambon C F, Letley D P, Stranges A, Marchet A, Rhead JL, et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008; 135:91-99; PMID:18474244; http://dx.doi.org/10.1053/j.gastro.2008.03.041.
111. Batista SA, Rocha GA, Rocha AM, Saraiva IE, Cabral MM, Oliveira RC, et al. Higher number of Helicobacter pylori CagA EPIYA C phosphorylation sites increases the risk of gastric cancer, but not duodenal ulcer. BMC Microbiol 2011; 11:61; PMID:21435255; http://dx.doi.org/10.1186/1471-2180-11-61.
112. Ferreira RM, Machado JC, Leite M, Carneiro F, Figueiredo C. The number of Helicobacter pylori CagA EPIYA C tyrosine phosphorylation motifs influenc-es the pattern of gastritis and the development of gastric carcinoma. Histopathology 2012; 60:992-998; PMID:22348604; http://dx.doi.org/10.1111/j.1365-2559.2012.04190.x.
113. Sicinschi LA, Correa P, Peek RM, Camargo MC, Piazuelo MB, Romero-Gallo J, et al. CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect 2010; 16:369-378; PMID:19456839; http://dx.doi.org/10.1111/j.1469-0691.2009.02811.x.
114. Acosta N, Quiroga A, Delgado P, Bravo MM, Jaramillo C. Helicobacter pylori CagA protein polymorphisms and their lack of association with pathogenesis. World J Gastroenterol 2010; 16:3936-3943; PMID:20712055; http://dx.doi.org/10.3748/wjg.v16.i31.3936.
115. Rizzato C, Torres J, Plummer M, Muñoz N, Franceschi S, Camorlinga-Ponce M, et al. Variations in Helicobacter pylori cytotoxin-associated genes and their influence in progression to gastric cancer: implications for preven-tion. PLoS One 2012; 7:e29605; PMID:22235308; http://dx.doi.org/10.1371/journal.pone.0029605.
116. Figura N, Moretti E, Roviello F, Papini F, Marrelli D. Caga structural types of Helicobacter pylori strains isolated from patients with gastric carcinoma and chronic gastritis only. Intern Emerg Med 2012; 7(Suppl 2):S103-S105; PMID:22311514; http://dx.doi.org/10.1007/s11739-012-0759-z.
117. Choi KD, Kim N, Lee DH, Kim JM, Kim JS, Jung HC, et al. Analysis of the 3' variable region of the cagA gene of Helicobacter pylori isolated in Koreans. Dig Dis Sci 2007; 52:960-966; PMID:17342405; http://dx.doi.org/10.1007/s10620-005-9030-z.
118. Yamada K, Sugiyama T, Mihara H, Kajiura S, Saito S, Itaya Y, et al. Fragmented CagA protein is highly immunoreactive in Japanese patients. Helicobacter 2012; 17:187-192; PMID:22515356; http://dx.doi.org/10.1111/j.1523-5378.2011.00930.x.
119. Jones KR, Joo YM, Jang S, Yoo YJ, Lee HS, Chung IS, et al. Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J Clin Microbiol 2009; 47:959-968; PMID:19158258; http://dx.doi.org/10.1128/JCM.02330-08.
120. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoi-etic neoplasms in mouse. Proc Natl Acad Sci U S A 2008; 105:1003-1008; PMID:18192401; http://dx.doi.org/10.1073/pnas.0711183105.
121. Miura M, Ohnishi N, Tanaka S, Yanagiya K, Hatakeyama M. Differential oncogenic potential of geographically distinct Helicobacter pylori CagA isoforms in mice. Int J Cancer 2009; 125:2497-2504; PMID:19588494; http://dx.doi.org/10.1002/ijc.24740.
122. Botham CM, Wandler AM, Guillemin K. A trans-genic Drosophila model demonstrates that the Helicobacter pylori CagA protein functions as a eukary-otic Gab adaptor. PLoS Pathog 2008; 4:e1000064; PMID:18483552; http://dx.doi.org/10.1371/journal. ppat.1000064.
123. Muyskens JB, Guillemin K. Helicobacter pylori CagA disrupts epithelial patterning by activating myosin light chain. PLoS One 2011; 6:e17856; PMID:21445303; http://dx.doi.org/10.1371/journal.pone.0017856.
124. Bourzac KM, Botham CM, Guillemin K. Helicobacter pylori CagA induces AGS cell elongation through a cell retraction defect that is independent of Cdc42, Rac1, and Arp2/3. Infect Immun 2007; 75:1203-1213; PMID:17194805; http://dx.doi.org/10.1128/IAI.01702-06.
125. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004; 113:321-333; PMID:14755326.
126. Rassow J, Meinecke M. Helicobacter pylori VacA: a new perspective on an invasive chloride channel. Microbes Infect 2012; 14:1026-1033; PMID:22796385; http://dx.doi.org/10.1016/j.micinf.2012.07.002.
127. Leunk RD, Johnson P T, David BC, Kraft WG, Morgan DR. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26:93-99; PMID:3385767; http://dx.doi.org/10.1099/00222615-26-2-93.
128. Boquet P, Ricci V. Intoxication strategy of Helicobacter pylori VacA toxin. Trends Microbiol 2012; 20:165-174; PMID:22364673; http://dx.doi.org/10.1016/j.tim.2012.01.008.
129. Kim IJ, Blanke SR. Remodeling the host environ-ment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA). Front Cell Infect Microbiol 2012; 2:37; PMID:22919629; http://dx.doi.org/10.3389/fcimb.2012.00037.
130. Lupetti P, Heuser JE, Manetti R, Massari P, Lanzavecchia S, Bellon PL, et al. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J Cell Biol 1996; 133:801-807; PMID:8666665; http://dx.doi.org/10.1083/jcb.133.4.801.
131. Gupta VR, Patel HK, Kostolansky SS, Ballivian RA, Eichberg J, Blanke SR. Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. PLoS Pathog 2008; 4:e1000073; PMID:18497859; http://dx.doi.org/10.1371/journal.ppat.1000073.
132. Asahi M, Tanaka Y, Izumi T, Ito Y, Naiki H, Kersulyte D, et al. Helicobacter pylori CagA containing ITAM-like sequences localized to lipid rafts negatively regulates VacA-induced signaling in vivo. Helicobacter 2003; 8:1-14; PMID:12603611; http://dx.doi.org/10.1046/j.1523-5378.2003.00118.x.
133. Schraw W, Li Y, McClain MS, van der Goot FG, Cover TL. Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts. J Biol Chem 2002; 277:34642-34650; PMID:12121984; http://dx.doi.org/10.1074/jbc.M203466200.
134. Gupta VR, Wilson BA, Blanke SR. Sphingomyelin is important for the cellular entry and intracellular localization of Helicobacter pylori VacA. Cell Microbiol 2010; 12:1517-1533; PMID:20545942; http://dx.doi.org/10.1111/j.1462-5822.2010.01487.x.
135. Palframan SL, Kwok T, Gabriel K. Vacuolating cyto-toxin A (VacA), a key toxin for Helicobacter pylo-ri pathogenesis. Front Cell Infect Microbiol 2012; 2:92; PMID:22919683; http://dx.doi.org/10.3389/fcimb.2012.00092.
136. Backert S, Tegtmeyer N. The versatility of the Helicobacter pylori vacuolating cytotoxin vacA in signal transduction and molecular crosstalk. Toxins (Basel) 2010; 2:69-92; PMID:22069547; http://dx.doi.org/10.3390/toxins2010069.
137. Ayala G, Galván-Portillo M, Chihu L, Fierros G, Sánchez A, Carrillo B, et al.; Study Group. Resistance to antibiotics and characterization of Helicobacter pylori strains isolated from antrum and body from adults in Mexico. Microb Drug Resist 2011; 17:149-155; PMID:21303219; http://dx.doi.org/10.1089/mdr.2010.0154.
138. Atherton JC, Cao P, Peek RM Jr., Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270:17771-17777; PMID:7629077; http://dx.doi.org/10.1074/jbc.270.30.17771.
139. Rhead JL, Letley D P, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, et al. A new Helicobacter pylori vacuolating cytotoxin deter-minant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007; 133:926-936; PMID:17854597; http://dx.doi.org/10.1053/j.gas-tro.2007.06.056.
140. Ogiwara H, Sugimoto M, Ohno T, Vilaichone RK, Mahachai V, Graham DY, et al. Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastro-duodenal diseases. J Clin Microbiol 2009; 47:3493-3500; PMID:19726606; http://dx.doi.org/10.1128/JCM.00887-09.
141. Chung C, Olivares A, Torres E, Yilmaz O, Cohen H, Perez-Perez G. Diversity of VacA intermediate region among Helicobacter pylori strains from several regions of the world. J Clin Microbiol 2010; 48:690-696; PMID:20053862; http://dx.doi.org/10.1128/JCM.01815-09.
142. Meining A, Stolte M, Hatz R, Lehn N, Miehlke S, Morgner A, et al. Differing degree and distribution of gastritis in Helicobacter pylori-associated diseases. Virchows Arch 1997; 431:11-15; PMID:9247628; http://dx.doi.org/10.1007/s004280050063.
143. Miehlke S, Hackelsberger A, Meining A, Hatz R, Lehn N, Malfertheiner P, et al. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer 1998; 78:263-266; PMID:9683304; http://dx.doi.org/10.1038/bjc.1998.475.
144. Miehlke S, Kirsch C, Agha-Amiri K, Günther T, Lehn N, Malfertheiner P, et al. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer 2000; 87:322-327; PMID:10897035; http://dx.doi.org/10.1002/1097-0215(20000801)87:3322::AID-IJC33.0.CO;2-M.
145. Letley D P, Rhead JL, Twells RJ, Dove B, Atherton JC. Determinants of non-toxicity in the gastric pathogen Helicobacter pylori. J Biol Chem 2003; 278:26734-26741; PMID:12738773; http://dx.doi.org/10.1074/jbc.M304071200.
146. McClain MS, Cao P, Iwamoto H, Vinion-Dubiel AD, Szabo G, Shao Z, et al. A 12-amino-acid segment, pres-ent in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters mem-brane channel formation. J Bacteriol 2001; 183:6499-6508; PMID:11673417; http://dx.doi.org/10.1128/JB.183.22.6499-6508.2001.
147. Letley D P, Atherton JC. Natural diversity in the N terminus of the mature vacuolating cytotoxin of Helicobacter pylori determines cytotoxin activity. J Bacteriol 2000; 182:3278-3280; PMID:10809711; http://dx.doi.org/10.1128/JB.182.11.3278-3280.2000.
148. Yordanov D, Boyanova L, Markovska R, Gergova G, Mitov I. Significance of Helicobacter pylori vacA intermediate region genotyping-a Bulgarian study. Diagn Microbiol Infect Dis 2012; 74:253-257; PMID:22951332; http://dx.doi.org/10.1016/j.diagmi-crobio.2012.07.008.
149. Breurec S, Michel R, Seck A, Brisse S, Come D, Dieye FB, et al. Clinical relevance of cagA and vacA gene polymorphisms in Helicobacter pylori isolates from Senegalese patients. Clinical microbiology and infec-tion 2012; 18:153-159.
150. Jang S, Jones KR, Olsen CH, Joo YM, Yoo YJ, Chung IS, et al. Epidemiological link between gastric dis-ease and polymorphisms in VacA and CagA. J Clin Microbiol 2010; 48:559-567; PMID:19955279; http://dx.doi.org/10.1128/JCM.01501-09.
151. Panayotopoulou EG, Sgouras DN, Papadakos KS, Petraki K, Breurec S, Michopoulos S, et al. CagA and VacA polymorphisms are associated with distinct pathological features in Helicobacter pylori-infected adults with peptic ulcer and non-peptic ulcer disease. J Clin Microbiol 2010; 48:2237-2239; PMID:20392907; http://dx.doi.org/10.1128/JCM.00662-10.
152. Erzin Y, Koksal V, Altun S, Dobrucali A, Aslan M, Erdamar S, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspep-sia. Helicobacter 2006; 11:574-580; PMID:17083380; http://dx.doi.org/10.1111/j.1523-5378.2006.00461.x.
153. van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, de Boer W, et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998; 115:58-66; PMID:9649459; http://dx.doi.org/10.1016/S0016-5085(98)70365-8.
154. Warburton VJ, Everett S, Mapstone N P, Axon AT, Hawkey P, Dixon M F. Clinical and histological associa-tions of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol 1998; 51:55-61; PMID:9577374; http://dx.doi.org/10.1136/jcp.51.1.55.
155. González CA, Figueiredo C, Lic CB, Ferreira RM, Pardo ML, Ruiz Liso JM, et al. Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Am J Gastroenterol 2011; 106:867-874; PMID:21285949; http://dx.doi.org/10.1038/ajg.2011.1.
156. Markovska R, Boyanova L, Yordanov D, Gergova G, Mitov I. Helicobacter pylori oipA genetic diversity and its associations with both disease and cagA, vacA s, m, and i alleles among Bulgarian patients. Diagn Microbiol Infect Dis 2011; 71:335-340; PMID:21937185; http://dx.doi.org/10.1016/j.diagmicrobio.2011.08.008.
157. Figueroa G, Troncoso M, Toledo MS, Faúndez G, Acuña R. Prevalence of serum antibodies to Helicobacter pylori VacA and CagA and gastric diseases in Chile. J Med Microbiol 2002; 51:300-304; PMID:11926734.
158. Rudi J, Kolb C, Maiwald M, Zuna I, von Herbay A, Galle PR, et al. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci 1997; 42:1652-1659; PMID:9286230; http://dx.doi.org/10.1023/A:1018849112533.
159. de Figueiredo Soares T, de Magalhães Queiroz DM, Mendes EN, Rocha GA, Rocha Oliveira AM, Alvares Cabral MM, et al. The interrelationship between Helicobacter pylori vacuolating cytotoxin and gastric carcinoma. Am J Gastroenterol 1998; 93:1841-1847; PMID:9772042; http://dx.doi.org/10.1016/S0002-9270(98)00414-6.
160. Boukhris SA, Benajah DA, El Rhazi K, Ibrahimi SA, Nejjari C, Amarti A, et al. Prevalence and distribution of Helicobacter pylori cagA and vacA genotypes in the Moroccan population with gastric disease. European journal of clinical microbiology & infectious diseases 2011; PMID:22160824.
161. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter 1998; 3:241-253; PMID:9844065; http://dx.doi.org/10.1046/j.1523-5378.1998.08056.x.
162. Ortiz-Princz D, Guariglia-Oropeza V, Avila M, Correnti M, Perrone M, Gutierrez B, et al. Helicobacter pylori cagA and vacA genotypes in Cuban and Venezuelan populations. Mem Inst Oswaldo Cruz 2010; 105:331-335; PMID:20512250; http://dx.doi.org/10.1590/S0074-02762010000300016.
163. Perng CL, Lin HJ, Sun IC, Tseng GY, Facg. Helicobacter pylori cagA, iceA and vacA status in Taiwanese patients with peptic ulcer and gastritis. J Gastroenterol Hepatol 2003; 18:1244-1249; PMID:14535980; http://dx.doi.org/10.1046/j.1440-1746.2003.03214.x.
164. Chen XJ, Yan J, Shen Y F. Dominant cagA/vacA geno-types and coinfection frequency of H. pylori in peptic ulcer or chronic gastritis patients in Zhejiang Province and correlations among different genotypes, coinfec-tion and severity of the diseases. Chin Med J (Engl) 2005; 118:460-467; PMID:15788126.
165. Khodaii Z, Ghaderian SM, Akbarzadeh Najar R, Nejati H, Tabatabaei Panah AS. cagA and vacA sta-tus and influence of Helicobacter pylori infection on serum oxidative DNA damage in Iranian patients with peptic ulcer disease. Ir J Med Sci 2011; 180:155-161; PMID:20721697; http://dx.doi.org/10.1007/s11845-010-0548-5.
166. Jafari F, Shokrzadeh L, Dabiri H, Baghaei K, Yamaoka Y, Zojaji H, et al. vaca genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. Jpn J Infect Dis 2008; 61:290-293; PMID:18653971.
167. Tuncel IE, Hussein NR, Bolek BK, Arikan S, Salih BA. Helicobacter pylori virulence factors and their role in peptic ulcer diseases in Turkey. Acta Gastroenterol Belg 2010; 73:235-238; PMID:20690562.
168. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999; 37:2274-2279; PMID:10364597.
169. Andreson H, Lõivukene K, Sillakivi T, Maaroos HI, Ustav M, Peetsalu A, et al. Association of cagA and vacA genotypes of Helicobacter pylori with gastric diseases in Estonia. J Clin Microbiol 2002; 40:298-300; PMID:11773138; http://dx.doi.org/10.1128/JCM.40.1.298-300.2002.
170. Ito Y, Azuma T, Ito S, Miyaji H, Hirai M, Yamazaki Y, et al. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 1997; 35:1710-1714; PMID:9196179.
171. Tanih NF, McMillan M, Naidoo N, Ndip LM, Weaver LT, Ndip RN. Prevalence of Helicobacter pylori vacA, cagA and iceA genotypes in South African patients with upper gastrointestinal diseases. Acta Trop 2010; 116:68-73; PMID:20529658; http://dx.doi.org/10.1016/j.actatropica.2010.05.011.
172. Yamaoka Y, Kodama T, Kashima K, Graham DY. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol 1999; 52:215-218; PMID:10450182; http://dx.doi.org/10.1136/jcp.52.3.215.
173. Shimoyama T, Neelam B, Fukuda S, Tanaka M, Munakata A, Crabtree JE. VacA seropositivity is not associated with the development of gastric cancer in a Japanese population. Eur J Gastroenterol Hepatol 1999; 11:887-890; PMID:10514122; http://dx.doi.org/10.1097/00042737-199908000-00013.
174. Suriani R, Colozza M, Cardesi E, Mazzucco D, Marino M, Grosso S, et al. CagA and VacA Helicobacter pylori antibodies in gastric cancer. Can J Gastroenterol 2008; 22:255-258; PMID:18354754.
175. Ben Mansour K, Fendri C, Zribi M, Masmoudi A, Labbene M, Fillali A, et al. Prevalence of Helicobacter pylori vacA, cagA, iceA and oipA genotypes in Tunisian patients. Ann Clin Microbiol Antimicrob 2010; 9:10; PMID:20302630; http://dx.doi.org/10.1186/1476-0711-9-10.
176. Yokoyama K, Higashi H, Ishikawa S, Fujii Y, Kondo S, Kato H, et al. Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epi-thelial cells. Proc Natl Acad Sci U S A 2005; 102:9661-9666; PMID:15980153; http://dx.doi.org/10.1073/pnas.0502529102.
177. Argent RH, Thomas RJ, Letley D P, Rittig MG, Hardie KR, Atherton JC. Functional association between the Helicobacter pylori virulence factors VacA and CagA. J Med Microbiol 2008; 57:145-150; PMID:18201978; http://dx.doi.org/10.1099/jmm.0.47465-0.
178. Tegtmeyer N, Zabler D, Schmidt D, Hartig R, Brandt S, Backert S. Importance of EGF receptor, HER2/Neu and Erk1/2 kinase signalling for host cell elonga-tion and scattering induced by the Helicobacter pylori CagA protein: antagonistic effects of the vacuolating cytotoxin VacA. Cell Microbiol 2009; 11:488-505; PMID:19046339; http://dx.doi.org/10.1111/j.1462-5822.2008.01269.x.
179. Oldani A, Cormont M, Hofman V, Chiozzi V, Oregioni O, Canonici A, et al. Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog 2009; 5:e1000603; PMID:19798427; http://dx.doi.org/10.1371/journal.ppat.1000603.
180. Akada JK, Aoki H, Torigoe Y, Kitagawa T, Kurazono H, Hoshida H, et al. Helicobacter pylori CagA inhibits endocytosis of cytotoxin VacA in host cells. Dis Model Mech 2010; 3:605-617; PMID:20682750; http://dx.doi.org/10.1242/dmm.004879.
181. Tan S, Noto JM, Romero-Gallo J, Peek RM Jr., Amieva MR. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog 2011; 7:e1002050; PMID:21589900; http://dx.doi.org/10.1371/journal.ppat.1002050.
182. Jones KR, Jang S, Chang JY, Kim J, Chung IS, Olsen CH, et al. Polymorphisms in the intermediate region of VacA impact Helicobacter pylori-induced disease development. J Clin Microbiol 2011; 49:101-110; PMID:21084502; http://dx.doi.org/10.1128/JCM.01782-10.
183. Oertli M, Sundquist M, Hitzler I, Engler DB, Arnold IC, Reuter S, et al. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest 2012; 122:1082-1096; PMID:22307326; http://dx.doi.org/10.1172/JCI61029.
184. Blaser MJ, Chen Y, Reibman J. Does Helicobacter pylori protect against asthma and allergy? Gut 2008; 57:561-567; PMID:18194986; http://dx.doi.org/10.1136/gut.2007.133462.
185. Dooley C P, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321:1562-1566; PMID:2586553; http://dx.doi.org/10.1056/NEJM198912073212302.
186. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastro-duodenal ulcer and gastric cancer. Annu Rev Microbiol 2000; 54:615-640; PMID:11018139; http://dx.doi.org/10.1146/annurev.micro.54.1.615.
187. Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 2010; 16:1077-1084; PMID:19760778; http://dx.doi.org/10.1002/ibd.21116.
188. Luther J, Owyang SY, Takeuchi T, Cole TS, Zhang M, Liu M, et al. Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced coli-tis. Gut 2011; 60:1479-1486; PMID:21471567; http://dx.doi.org/10.1136/gut.2010.220087.
189. Rožankovic PB, Huzjan AL, Cupic H, Bencic IJ, Bašic S, Demarin V. Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease. J Neurol 2011; 258:753-761; PMID:21085982; http://dx.doi.org/10.1007/s00415-010-5824-9.
190. Longo-Mbenza B, Nsenga JN, Mokondjimobe E, Gombet T, Assori IN, Ibara JR, et al. Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans. Vasc Health Risk Manag 2012; 6:455-461; PMID:22923995; http://dx.doi.org/10.2147/VHRM.S28680.
191. Bassi V, Marino G, Iengo A, Fattoruso O, Santinelli C. Autoimmune thyroid diseases and Helicobacter pylori: the correlation is present only in Graves's disease. World J Gastroenterol 2012; 18:1093-1097; PMID:22416184; http://dx.doi.org/10.3748/wjg.v18.i10.1093.
192. Boyanova L, Yordanov D, Gergova G, Markovska R, Mitov I. Benefits of Helicobacter pylori cagE geno-typing in addition to cagA genotyping: a Bulgarian study. Antonie Van Leeuwenhoek 2011; 100:529-535; PMID:21701821; http://dx.doi.org/10.1007/s10482-011-9608-8.
193. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymor-phisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402; PMID:10746728; http://dx.doi.org/10.1038/35006081.
194. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 2001; 412:99; PMID:11808612; http://dx.doi.org/10.1038/35083631.
195. Sicinschi LA, Lopez-Carrillo L, Camargo MC, Correa P, Sierra RA, Henry RR, et al. Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in inter-leukin-1 and -10 genes. Int J Cancer 2006; 118:649-657; PMID:16114018; http://dx.doi.org/10.1002/ijc.21364.
196. Chen W, Shu D, Chadwick VS. Helicobacter pylori infection: mechanism of colonization and functional dyspepsia Reduced colonization of gastric mucosa by Helicobacter pylori in mice deficient in interleu-kin-10. J Gastroenterol Hepatol 2001; 16:377-383; PMID:11354274; http://dx.doi.org/10.1046/j.1440-1746.2001.02459.x.
197. Azuma T, Ito S, Sato F, Yamazaki Y, Miyaji H, Ito Y, et al. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 1998; 82:1013-1018; PMID:9506344; http://dx.doi.org/10.1002/(SICI)1097-0142(19980315)82:61013::AID-CNCR23.0.CO;2-F.
198. de Oliveira JG, Silva AE. Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population. World J Gastroenterol 2012; 18:1235-1242; PMID:22468087; http://dx.doi.org/10.3748/wjg.v18.i11.1235.
199. Raju D, Hussey S, Ang M, Terebiznik MR, Sibony M, Galindo-Mata E, et al. Vacuolating cytotox-in and variants in Atg16L1 that disrupt autoph-agy promote Helicobacter pylori infection in humans. Gastroenterology 2012; 142:1160-1171; PMID:22333951; http://dx.doi.org/10.1053/j.gas-tro.2012.01.043.
200. Wang P, Zhang L, Jiang JM, Ma D, Tao HX, Yuan SL, et al. Association of NOD1 and NOD2 genes polymorphisms with Helicobacter pylori related gastric cancer in a Chinese population. World J Gastroenterol 2012; 18:2112-2120; PMID:22563200; http://dx.doi.org/10.3748/wjg.v18.i17.2112.
201. Goto Y, Ando T, Yamamoto K, Tamakoshi A, El-Omar E, Goto H, et al. Association between serum pepsino-gens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Int J Cancer 2006; 118:203-208; PMID:16032704; http://dx.doi.org/10.1002/ijc.21338.
202. Jiang J, Jia Z F, Kong F, Jin MS, Wang Y P, Tian S, et al. Association of polymorphism of PTPN 11 encoding SHP-2 with gastric atrophy but not gastric cancer in Helicobacter pylori seropositive Chinese population. BMC Gastroenterol 2012; 12:89; PMID:22788847; http://dx.doi.org/10.1186/1471-230X-12-89.
203. Skoog EC, Sjöling A, Navabi N, Holgersson J, Lundin SB, Lindén SK. Human gastric mucins differently regulate Helicobacter pylori proliferation, gene expres-sion and interactions with host cells. PLoS One 2012; 7:e36378; PMID:22563496; http://dx.doi.org/10.1371/journal.pone.0036378.
204. Zhong C, Li KN, Bi JW, Wang BC. Sodium intake, salt taste and gastric cancer risk according to helicobacter pylori infection, smoking, histological type and tumor site in china. Asian Pac J Cancer Prev 2012; 13:2481-2484; PMID:22938408; http://dx.doi.org/10.7314/APJCP.2012.13.6.2481.
205. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009; 7:887-894; PMID:19898491; http://dx.doi.org/10.1038/nrmicro2245.
206. Brenner H, Arndt V, Bode G, Stegmaier C, Ziegler H, Stümer T. Risk of gastric cancer among smok-ers infected with Helicobacter pylori. Int J Cancer 2002; 98:446-469; PMID:11920598; http://dx.doi.org/10.1002/ijc.10201.
207. Shikata K, Doi Y, Yonemoto K, Arima H, Ninomiya T, Kubo M, et al. Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence: the Hisayama Study. Am J Epidemiol 2008; 168:1409-1415; PMID:18945691; http://dx.doi.org/10.1093/aje/kwn276.
208. Wang XQ, Yan H, Terry PD, Wang JS, Cheng L, Wu WA, et al. Interactions between CagA and smoking in gastric cancer. World J Gastroenterol 2011; 17:3330-3334; PMID:21876621; http://dx.doi.org/10.3748/wjg.v17.i28.3330.